A9603 Injection, pafolacianine, 0.1 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj, pafolacianine, 0.1 mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, pafolacianine, 0.1 mg | yes |
Related codes in A96
- A9600 Strontium sr-89 chloride, therapeutic, per millicurie
- A9601 Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602 Fluorodopa f-18, diagnostic, per millicurie
- A9604 Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9606 Radium ra-223 dichloride, therapeutic, per microcurie
- A9607 Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
- A9608 Flotufolastat f 18, diagnostic, 1 millicurie
- A9609 Fludeoxyglucose f18 up to 15 millicuries
- A9610 Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- A9611 Flurpiridaz f 18, diagnostic, 1 millicurie
- A9612 Injection, fluorescein, 1 mg
- A9615 Injection, pegulicianine, 1 mg
- A9616 Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie
- A9697 Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose
- A9698 Non-radioactive contrast imaging material, not otherwise classified, per study
- A9699 Radiopharmaceutical, therapeutic, not otherwise classified